Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...
Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for ...
With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the ...
It was one year ago this month that Ashley McEvoy announced her surprising resignation as worldwide chair of J&J MedTech. She ...
Guggenheim raised the firm’s price target on Johnson & Johnson to $162 from $156 and keeps a Neutral rating on the shares. The firm ...
MedTech sales growth was led by electrophysiology and cardiovascular products. Johnson & Johnson’s adjusted net earnings margin stood at 26.1% during the quarter, compared to 31.7% in the prior ...
It has been nearly a year since my last Johnson & Johnson (NYSE:JNJ ... At that time, it looked as if the company’s MedTech division was going to be a primary growth driver, along with ...
Zacks.com on MSN10d
Top Stock Reports for Amazon.com, Johnson & Johnson and Boston ScientificToday's Research Daily features new research reports on 12 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson ...
Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback